Far-Red Light Triggered Production of Bispecific T Cell Engagers (BiTEs) from Engineered Cells for Antitumor Application.

Zhang, Cuilin; Shi, Yingjun; Wu, Lingjie; Wang, Chenyi; Liao, Naishun; Wang, Fei; Zhao, Bixing; Wang, Yingchao; Liu, Xiaolong

Zhang, Cuilin; Shi, Yingjun; Wu, Lingjie; Wang, Chenyi; Liao, Naishun; Wang, Fei; Zhao, Bixing; Wang, Yingchao; Liu, Xiaolong.

Afiliación

Zhang C; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, PR China.
Shi Y; The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, PR China.
Wu L; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, PR China.
Wang C; The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, PR China.
Liao N; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, PR China.
Wang F; The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, PR China.
Zhao B; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, PR China.
Wang Y; The Liver Center of Fujian Province, Fujian Medical University, Fuzhou 350025, PR China.
Liu X; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, PR China.

ACS Synth Biol ; 11(2): 888-899, 2022 02 18.

Article en En | MEDLINE | ID: mdl-35113526

Asunto(s)

Anticuerpos Biespecíficos; Carcinoma Hepatocelular; Neoplasias Hepáticas; Animales; Anticuerpos Biespecíficos/genética; Anticuerpos Biespecíficos/uso terapéutico; Carcinoma Hepatocelular/tratamiento farmacológico; Carcinoma Hepatocelular/patología; Glipicanos; Humanos; Neoplasias Hepáticas/tratamiento farmacológico; Neoplasias Hepáticas/patología; Mamíferos; Linfocitos T; Ensayos Antitumor por Modelo de Xenoinjerto

Palabras clave

GPC3; antitumor immunotherapy; bispecific T cell engager; engineered cells; far-red light; optogenetics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: ACS Synth Biol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google